Drug intelligence / Profile preview

Kangai Jingfang

Development stage
Unknown
Lead developer
Kaken Pharmaceutical
Administration
Oral
01

Overview

Kangai Jingfang is a traditional Chinese medicine formula, also referred to as Anticancer Essence Formula, that is being investigated for its therapeutic potential in treating advanced colorectal cancer. It is specifically studied for stage III - IV colorectal cancer characterized by spleen deficiency and essence deficiency types. The drug is administered orally.

Other names
Anticancer Essence Formula抗癌精方口服
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)MMP9 (Matrix metalloproteinase-9)VEGFA (Vascular endothelial growth factor A)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)HDAC1 (Histone Deacetylase 1)ESR1 (ERα)TP53 (Cellular Tumor Antigen p53 R175H)TNFR2/PI3K/AKT/NF-κB (Tumor necrosis factor receptor 2/Phosphoinositide 3-kinase/Protein kinase B/Nuclear factor kappa-light-chain-enhancer of activated B cells signaling axis)HSP90AA1 (Heat shock protein HSP90-alpha)AR (Adrenergic receptors)EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on Kangai Jingfang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kangai Jingfang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call